Western Pennsylvania's Guide to Good Health
HomeMedia KitCalendarRelated LinksCareers in HealthcareContact Us

The COMPASS Clinical Study

Pittsburgh area residents have the opportunity to participate in a clinical research study of an investigational treatment for patients with glaucoma who also are in need of cataract surgery.
Dr. John Nairn, an investigator at Associates in Ophthalmology, is conducting a study of an investigational device designed to reduce pressure in the eye. Buildup of eye pressure can damage the optic nerve of the eye causing glaucoma. The device, called the CyPass Implant, is placed in the eye at the time of cataract surgery. The CyPass Implant is “investigational”, which means it has not been approved by FDA for sale in the US.
 
Am I a Candidate?
You may be a candidate for this study if you:
• Are at least 45 years of age
• Have primary open angle glaucoma, and
• Have a cataract that needs to be removed.
Your eye doctor must also review your medical and ophthalmic history and perform a series of eye tests to further assess your eligibility to participate in the clinical study.
If you are interested in learning more details about the COMPASS Clinical Study, contact Michelle Colwell at Associates in Ophthalmology. She can be reached at (412) 653-3080 ext. 1041 or mcolwell@aioeyesurgeons.com.

________________________________________

For more articles, download the Spring '10 issue (PDF)

Top Of Page
   

Western Pennsylvania's Guide to Good Health. All rights reserved.
HOME | Media Kit | Calendar | Related Links | Careers in Healthcare | Contact Us

 
Download Now